These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19496920)

  • 1. Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø Study, Tromsø, Norway.
    Braekkan SK; Mathiesen EB; Njølstad I; Wilsgaard T; Størmer J; Hansen JB
    J Thromb Haemost; 2010 Jan; 8(1):157-62. PubMed ID: 19496920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effects of plasma von Willebrand factor and platelet measures on the risk of incident venous thromboembolism.
    Edvardsen MS; Hansen ES; Hindberg K; Morelli VM; Ueland T; Aukrust P; Brækkan SK; Evensen LH; Hansen JB
    Blood; 2021 Dec; 138(22):2269-2277. PubMed ID: 34161566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study.
    Jensvoll H; Blix K; Brækkan SK; Hansen JB
    PLoS One; 2014; 9(3):e92011. PubMed ID: 24642868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
    Brodin E; Lerstad G; Grimnes G; Brækkan SK; Vik A; Brox J; Svartberg J; Jorde R; Hansen JB
    Thromb Haemost; 2013 May; 109(5):885-90. PubMed ID: 23446951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette smoking and the risk of venous thromboembolism: the Tromsø Study.
    Enga KF; Braekkan SK; Hansen-Krone IJ; le Cessie S; Rosendaal FR; Hansen JB
    J Thromb Haemost; 2012 Oct; 10(10):2068-74. PubMed ID: 22882779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromsø study.
    Braekkan SK; Mathiesen EB; Njølstad I; Wilsgaard T; Størmer J; Hansen JB
    J Thromb Haemost; 2008 Nov; 6(11):1851-7. PubMed ID: 18665924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint Effect of Multiple Prothrombotic Genotypes and Mean Platelet Volume on the Risk of Incident Venous Thromboembolism.
    Jakobsen L; Frischmuth T; Brækkan SK; Hansen JB; Morelli VM
    Thromb Haemost; 2022 Nov; 122(11):1911-1920. PubMed ID: 35617954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of mean platelet volume with risk of venous thromboembolism and mortality in patients with cancer. Results from the Vienna Cancer and Thrombosis Study (CATS).
    Riedl J; Kaider A; Reitter EM; Marosi C; Jäger U; Schwarzinger I; Zielinski C; Pabinger I; Ay C
    Thromb Haemost; 2014 Apr; 111(4):670-8. PubMed ID: 24306221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglycemia, assessed according to HbA1c , and future risk of venous thromboembolism: the Tromsø study.
    Lerstad G; Brodin EE; Enga KF; Jorde R; Schirmer H; Njølstad I; Svartberg J; Braekkan SK; Hansen JB
    J Thromb Haemost; 2014; 12(3):313-9. PubMed ID: 24382156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body height and risk of venous thromboembolism: The Tromsø Study.
    Braekkan SK; Borch KH; Mathiesen EB; Njølstad I; Wilsgaard T; Hansen JB
    Am J Epidemiol; 2010 May; 171(10):1109-15. PubMed ID: 20418276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effect of high factor VIII levels and high mean platelet volume on the risk of future incident venous thromboembolism.
    Hansen ES; Edvardsen MS; Aukrust P; Ueland T; Hansen JB; Brækkan SK; Morelli VM
    J Thromb Haemost; 2023 Oct; 21(10):2844-2853. PubMed ID: 37393000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study.
    Rinde LB; Lind C; Småbrekke B; Njølstad I; Mathiesen EB; Wilsgaard T; Løchen ML; Hald EM; Vik A; Braekkan SK; Hansen JB
    J Thromb Haemost; 2016 Jun; 14(6):1183-91. PubMed ID: 27061154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carotid atherosclerosis predicts future myocardial infarction but not venous thromboembolism: the Tromso study.
    Hald EM; Lijfering WM; Mathiesen EB; Johnsen SH; Løchen ML; Njølstad I; Wilsgaard T; Rosendaal FR; Brækkan SK; Hansen JB
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):226-30. PubMed ID: 24177328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism and subsequent permanent work-related disability.
    Braekkan SK; Grosse SD; Okoroh EM; Tsai J; Cannegieter SC; Naess IA; Krokstad S; Hansen JB; Skjeldestad FE
    J Thromb Haemost; 2016 Oct; 14(10):1978-1987. PubMed ID: 27411161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous sex hormone levels in men are not associated with risk of venous thromboembolism: the Tromso study.
    Svartberg J; Braekkan SK; Laughlin GA; Hansen JB
    Eur J Endocrinol; 2009 May; 160(5):833-8. PubMed ID: 19208774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red cell distribution width is associated with incident venous thromboembolism (VTE) and case-fatality after VTE in a general population.
    Ellingsen TS; Lappegård J; Skjelbakken T; Brækkan SK; Hansen JB
    Thromb Haemost; 2015 Jan; 113(1):193-200. PubMed ID: 25274492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet function as a risk factor for venous thromboembolism in the Framingham Heart Study.
    Puurunen MK; Hwang SJ; O'Donnell CJ; Tofler G; Johnson AD
    Thromb Res; 2017 Mar; 151():57-62. PubMed ID: 28152437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated measurements of carotid atherosclerosis and future risk of venous thromboembolism: the Tromsø Study.
    Småbrekke B; Rinde LB; Hald EM; Njølstad I; Mathiesen EB; Johnsen SH; Hansen JB; Braekkan SK; Lijfering WM
    J Thromb Haemost; 2017 Dec; 15(12):2344-2351. PubMed ID: 28981216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family history of myocardial infarction and cause-specific risk of myocardial infarction and venous thromboembolism: the Tromsø Study.
    Lind C; Enga KF; Mathiesen EB; Njølstad I; Brækkan SK; Hansen JB
    Circ Cardiovasc Genet; 2014 Oct; 7(5):684-91. PubMed ID: 25087051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mean platelet volume as a predictive marker for venous thromboembolism and mortality in patients treated for diffuse large B-cell lymphoma.
    Rupa-Matysek J; Gil L; Kroll-Balcerzak R; Barańska M; Komarnicki M
    Hematol Oncol; 2017 Dec; 35(4):456-464. PubMed ID: 27377517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.